How much does stem cell therapy for COPD & Lung Disease cost? (2026)
The comparison dataset stores a Bulgaria planning observation of €3,000–€8,000 for treatment, compiled from cited public commercial sources. It is not a quotation from Stem Plus, and different products, doses, visits and inclusions must not be treated as equivalent. The stored registry query contains 34 COPD & Lung Disease records. Registration does not mean that a study is recruiting, that a person is eligible, or that treatment and travel are free; verify the current record and sponsor-cost terms directly.
Chronic obstructive pulmonary disease (COPD) is persistent airflow limitation associated with airway and lung-tissue damage, commonly from smoking or other exposures. MSC and exosome research explores inflammatory and repair pathways, but intravenous distribution, laboratory signalling or an imaging change does not establish restored alveoli, improved survival or prevention of exacerbations.
What drives the cost for COPD & Lung Disease
Itemise respiratory assessment, product, administration, pulmonary rehabilitation, medicines, oxygen, travel, follow-up and management of infection, exacerbation or hospitalisation. A commercial infusion quote is not comparable with long-term evidence-based COPD care and must not divert resources from smoking cessation or established treatment.
Human studies are heterogeneous and generally investigational. They should be assessed by exact product, dose, route, COPD phenotype and severity, comparator, lung function, exercise capacity, symptoms, exacerbations, hospitalisation and adverse events. The FDA consumer alert states that the promoted regenerative products it addresses have not been approved in the United States for pulmonary diseases including COPD. Do not stop inhaled medicines, oxygen or rehabilitation for an experimental offer.
COPD & Lung Disease cost by country — comparison (2026)
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | Verify provider and laboratory certificates |
| USA | €4,600–€46,000 | Non-EU; verify provider and product status |
| UK | €4,880–€49,000 | Non-EU; verify provider and product status |
| Germany | €11,000–€36,700 | EU member state; verify provider and product status |
| Switzerland | €20,000–€40,000 | Non-EU; verify provider and product status |
| Mexico | €3,000–€12,000 | Non-EU; verify provider and product status |
| India | €3,000–€8,000 | Non-EU; verify provider and product status |
| Serbia | €7,000–€31,000 | Non-EU; verify provider and product status |
| Turkey | €6,000–€18,000 | Non-EU; verify provider and product status |
| Thailand | €8,000–€20,000 | Non-EU; verify provider and product status |
| Panama | €15,000–€27,000 | Non-EU; verify provider and product status |
Price varies with cell type, dose, number of sessions, diagnostics, supportive care and follow-up. A lower range does not establish equivalent quality or outcome. Request a fixed written quote and verify the therapy and provider with the relevant authorities. Check registered trials before paying privately.
COPD & Lung Disease cost — common questions
Why is COPD & Lung Disease stem-cell treatment so much cheaper in Bulgaria?
The collected commercial ranges differ, but they may describe different products, doses, visits and inclusions. A lower quote does not establish equivalent quality, evidence or regulatory status.
Is a cheaper programme riskier?
Price alone cannot establish risk. Verify the exact treatment status, provider and manufacturing authorisations, product identity, release testing, adverse-event plan and primary evidence.
Does the price include travel and hotel?
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
Will I get a fixed quote, or an open-ended bill?
Ask for a written quotation after clinical review, with the exact product, inclusions, exclusions, cancellation terms and circumstances in which charges may change. A website estimate is not a binding quote.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for COPD & Lung Disease (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.